A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High Risk Current and Former Smokers

Lung cancer chemoprevention, especially in high-risk former smokers, has great potential to reduce lung cancer incidence and mortality. Thiazolidinediones prevent lung cancer in preclinical studies, and diabetics receiving thiazolidinediones have lower lung cancer rates which led to our double-blind...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Prev Res (Phila)
Main Authors: Keith, Robert L., Blatchford, Patrick J., Merrick, Daniel T., Bunn, Paul A., Bagwell, Brandi, Dwyer-Nield, Lori D., Jackson, Mary K., Geraci, Mark W., Miller, York E.
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6774885/
https://ncbi.nlm.nih.gov/pubmed/31308004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-19-0006
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares